Investor Sues Medtronic Over Alleged Infuse Scheme
By Christie Smythe ( January 9, 2009, 12:00 AM EST) -- A shareholder of medical technology company Medtronic Inc. has filed a derivative suit alleging that the company's directors and executives inflated the company's earnings through a physician kickback scheme and other unlawful promotion of the off-label use of its Infuse Bone Graft product, which has been linked to serious health complications....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.